• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肝硬化肝脏肝细胞癌(HCC)的 MDCT 特征。

MDCT features of hepatocellular carcinoma (HCC) in non-cirrhotic liver.

机构信息

Service de radiologie, hôpital Brabois, allée du Morvan, 54511 Vandœuvre-lès-Nancy, France.

Service de radiologie, hôpital Brabois, allée du Morvan, 54511 Vandœuvre-lès-Nancy, France.

出版信息

Diagn Interv Imaging. 2016 Mar;97(3):355-60. doi: 10.1016/j.diii.2015.09.007. Epub 2015 Nov 3.

DOI:10.1016/j.diii.2015.09.007
PMID:26546291
Abstract

PURPOSE

To describe the multidetector row computed tomography (MDCT) imaging features of HCC that develops in patients who are free from underlying liver cirrhosis and to determine if the MDCT presentation of this specific tumor differs from that of the more common HCC that develops in patients with liver cirrhosis using a retrospective case-control study.

PATIENTS AND METHODS

The MDCT examinations of 38 patients with HCC in non-cirrhotic liver (group 1) were quantitatively and qualitatively analyzed and compared to those obtained in 38 patients with HCC in cirrhotic liver (group 2) matched for age and gender. Quantitative and qualitative characteristics of HCC of both groups were compared using univariate analysis.

RESULTS

HCCs were significantly larger in group 1 (81.5mm±55.5) than in group 2 (44.5mm±39.1 SD; P=0.0015). In group 1, HCCs were more frequently single tumors (87%) than in group 2 (37%) (P<0.0001), encapsulated (92% vs. 47% respectively; P<0.0001), had more frequently fatty component (24% vs. 8%, respectively; P=0.0279) and internal hemorrhage (29% vs. 3%, respectively; P=0.0033). No significant differences were found between the two groups for location, hyperenhancement of HCC during the arterial phase, washout during the portal phase, endoluminal portal involvement by HCC, endoportal cruoric thrombus, invasion of adjacent organs and underlying liver steatosis.

CONCLUSION

HCC in non-cirrhotic liver are larger than those observed in cirrhotic liver and more frequently present as a single encapsulated tumor. They have the same patterns of enhancement than HCC that develops in cirrhotic liver.

摘要

目的

描述不伴有肝硬化的肝癌患者多排螺旋 CT(MDCT)的影像学特征,并通过回顾性病例对照研究,确定该特定肿瘤的 MDCT 表现是否与更常见的在肝硬化患者中发生的肝癌不同。

方法

对 38 例不伴肝硬化的肝癌患者(第 1 组)的 MDCT 检查进行定量和定性分析,并与 38 例伴有肝硬化的肝癌患者(第 2 组)的 MDCT 检查进行比较,两组患者在年龄和性别上相匹配。使用单变量分析比较两组 HCC 的定量和定性特征。

结果

第 1 组 HCC 的大小明显大于第 2 组(81.5mm±55.5 比 44.5mm±39.1,P=0.0015)。第 1 组 HCC 多为单发肿瘤(87%比 47%,P<0.0001),包膜完整(92%比 47%,P<0.0001),更常含有脂肪成分(24%比 8%,P=0.0279)和内部出血(29%比 3%,P=0.0033)。两组患者在肿瘤位置、动脉期 HCC 强化、门静脉期廓清、 HCC 累及门静脉内段、门静脉内积血、邻近器官侵犯和基础肝脂肪变性等方面无显著差异。

结论

不伴有肝硬化的肝癌比伴有肝硬化的肝癌体积更大,更常表现为单发包膜完整的肿瘤。它们与在肝硬化中发生的肝癌具有相同的强化模式。

相似文献

1
MDCT features of hepatocellular carcinoma (HCC) in non-cirrhotic liver.非肝硬化肝脏肝细胞癌(HCC)的 MDCT 特征。
Diagn Interv Imaging. 2016 Mar;97(3):355-60. doi: 10.1016/j.diii.2015.09.007. Epub 2015 Nov 3.
2
Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI.非酒精性脂肪性肝病相关肝细胞癌:肝脂肪变性对MRI上主要肝细胞癌特征的影响
Br J Radiol. 2018 Dec;91(1092):20180345. doi: 10.1259/bjr.20180345. Epub 2018 Aug 29.
3
Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.使用钆塞酸二钠增强磁共振成像和扩散加权磁共振成像对肝炎后肝硬化患者小肝细胞癌(≤2.0 cm)诊断标准的验证
Acta Radiol. 2013 Mar 1;54(2):127-36. doi: 10.1258/ar.2012.120262. Epub 2012 Nov 12.
4
CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.320例肝细胞癌和肝内胆管细胞癌患者的对比增强超声检查——早期或晚期洗脱的重要性:DEGUM多中心试验的亚分析
Ultraschall Med. 2015 Apr;36(2):132-9. doi: 10.1055/s-0034-1399147. Epub 2015 Mar 26.
5
Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants.多排螺旋计算机断层扫描(MDCT)在肝硬化患者肝移植候选者中诊断肝细胞癌:影像学血管模式的发生率和与肝移植标本的组织学相关性。
Eur Radiol. 2010 Apr;20(4):898-907. doi: 10.1007/s00330-009-1622-0. Epub 2009 Oct 3.
6
Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.肝硬化肝癌发生的超声造影研究。
Chin Med J (Engl). 2012 Sep;125(17):3104-9.
7
Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.肝硬化性肝病中的肝细胞癌:利用灌注成像的功能计算机断层扫描评估肿瘤血管生成
Acad Radiol. 2008 Jul;15(7):919-27. doi: 10.1016/j.acra.2008.02.005.
8
Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?肝硬化患者初发和复发性结节的超声造影特征:应采用哪些血管标准?
Ultraschall Med. 2013 Jun;34(3):280-7. doi: 10.1055/s-0033-1335024. Epub 2013 Apr 24.
9
Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout.多排螺旋 CT 检测肝硬化患者肝细胞癌:肝静脉期与延迟期对肿瘤洗脱的检测
Br J Radiol. 2011 May;84(1001):403-12. doi: 10.1259/bjr/18329080. Epub 2010 Nov 16.
10
Utility of non-contrast-enhanced CT for improved detection of arterial phase hyperenhancement in hepatocellular carcinoma.非增强CT在提高肝细胞癌动脉期高增强检测中的应用价值。
Abdom Imaging. 2014 Dec;39(6):1247-54. doi: 10.1007/s00261-014-0174-1.

引用本文的文献

1
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients.代谢相关脂肪性肝病患者肝细胞癌的流行病学、病理生理学和临床特征。
Hepatol Int. 2024 Oct;18(Suppl 2):922-940. doi: 10.1007/s12072-024-10692-4. Epub 2024 Jul 16.
2
Current Imaging Diagnosis of Hepatocellular Carcinoma.肝细胞癌的当前影像诊断
Cancers (Basel). 2022 Aug 18;14(16):3997. doi: 10.3390/cancers14163997.
3
Non-Cirrhotic Liver is Associated with Poor Prognosis of Hepatocellular Carcinoma: A Literature Review.非肝硬化肝脏与肝癌预后不良相关:文献综述。
Med Sci Monit. 2019 Sep 3;25:6615-6623. doi: 10.12659/MSM.915722.
4
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.非肝硬化肝脏中的肝细胞癌:全面综述
World J Hepatol. 2019 Jan 27;11(1):1-18. doi: 10.4254/wjh.v11.i1.1.